Silk Therapeutics Announces Issuance of New Patent to Support the Use of Silk Technology Within Consumer Goods and Medical Products

Leading Silk-Protein Company Leverages Science to Provide Silk Benefits Beyond Skin-Care

Oct 27, 2015, 09:22 ET from Silk Therapeutics, Inc.

MEDFORD, Mass., Oct. 27, 2015 /PRNewswire/ -- Silk Therapeutics Inc., a specialty biotechnology company innovating a silk protein product platform, today announced receipt from the United States Patent and Trademark Office ("USPTO") of a Notice of Allowance for US non-provisional patent application serial number 14/503,021, related to a new form of pure, natural and stable silk protein.

Claims in the patent application are the basis of Silk Therapeutics' technology platform that forms the foundation of the company's mission: improving human health through the ways in which individuals treat and enhance skin. The company plans to pursue applications beyond its anti-aging skincare line into other consumer and medical products that can benefit from the inherent safety, effectiveness and performance associated with natural silk.

"By utilizing advanced manufacturing technology, our goal was to create a reliable source of highly pure, natural, non-GMO silk protein," said Greg Altman, PhD, Chief Executive Officer, Silk Therapeutics. "Our technology platform will form the basis for products, where silk's unique ability to treat skin as well as stabilize and deliver active ingredients without the use of harsh chemicals and solvents can be leveraged."

Silk Therapeutics intends to pursue product opportunities that will eliminate the unnecessary use of unregulated chemicals used in today's consumer products. The company further hopes to pursue partnerships with product developers interested in health based applications.

About Silk Therapeutics
Silk Therapeutics, Inc., headquartered in Boston, MA, is the leader in silk protein solutions for human health and wellness. The founders of Silk Therapeutics are world-renowned as pioneers in silk science to improve human health. Dr. Greg Altman, CEO, and Dr. Rebecca Horan, Chief Operating Officer, have worked together for more than 15 years developing silk-based applications used in a number of medical products, and are currently focused on addressing unmet needs in the treatment and enhancement of skin. Dr. Horan's personal experience as a cancer survivor, and the company's commitment to the wellbeing of its customers, is the foundation for Silk Therapeutics pure, risk-free skincare that works naturally with the body. For more information, please visit

Media Contact

Christina Teves, Allison+Partners

Logo -  

SOURCE Silk Therapeutics, Inc.